2018
DOI: 10.1073/pnas.1814484116
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers

Abstract: Infectious diseases are associated with considerable morbidity and mortality worldwide. Although human, financial, substantial, and time resources are limited, it is unknown whether such resources are used effectively in research to manage diseases. The correlation between the disability-adjusted life years to represent disease burden and number of publications as a surrogate for research activity was investigated to measure burden-adjusted research intensity for 52 infectious diseases at global and country le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
41
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(46 citation statements)
references
References 18 publications
2
41
0
3
Order By: Relevance
“…The burden of NTDs is mostly nonexistent in affluent countries; instead, they predominantly affect the world’s poor, and are therefore less interesting for commercial research, as the chance of return of investment is limited. There is little incentive for affluent countries to deal with many NTDs, mainly due to the low impact these diseases have on the population of these countries [ 24 ]. This is also visible in drug development where, from 1975 to 2004, only 1% of drugs were developed for NTDs (21 out of 1556) [ 3 ].…”
Section: Researchmentioning
confidence: 99%
“…The burden of NTDs is mostly nonexistent in affluent countries; instead, they predominantly affect the world’s poor, and are therefore less interesting for commercial research, as the chance of return of investment is limited. There is little incentive for affluent countries to deal with many NTDs, mainly due to the low impact these diseases have on the population of these countries [ 24 ]. This is also visible in drug development where, from 1975 to 2004, only 1% of drugs were developed for NTDs (21 out of 1556) [ 3 ].…”
Section: Researchmentioning
confidence: 99%
“…Furthermore, using burden-adjusted research intensity, RSV research is underfunded and has seen a decline in spending during a period when influenza research has been progressively better funded. 2 In this review, we examine the epidemiology, immunology and contemporary research landscape of RSV disease in both children and in adults.…”
Section: Introductionmentioning
confidence: 99%
“…In our analysis, ε is also assumed to be uncorrelated. Thus, the regression equation can be written as: (1) where b i are the regression coefficients, x i are independent variables, and ε is the stochastic error associated with the regression.…”
Section: Bioinformatics Analysis Of Metagenome Datasetsmentioning
confidence: 99%